Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-26 @ 6:52 AM
Study NCT ID:
NCT06410950
Status:
COMPLETED
Last Update Posted:
2025-01-10
First Post:
2024-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mechanical Muscle Proprieties in Patient with COPD
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D029424', 'term': 'Pulmonary Disease, Chronic Obstructive'}, {'id': 'D018908', 'term': 'Muscle Weakness'}], 'ancestors': [{'id': 'D008173', 'term': 'Lung Diseases, Obstructive'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D002908', 'term': 'Chronic Disease'}, {'id': 'D020969', 'term': 'Disease Attributes'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D009135', 'term': 'Muscular Diseases'}, {'id': 'D009140', 'term': 'Musculoskeletal Diseases'}, {'id': 'D020879', 'term': 'Neuromuscular Manifestations'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'CROSS_SECTIONAL', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 87}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2024-05-13', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-09', 'completionDateStruct': {'date': '2025-01-09', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2025-01-09', 'studyFirstSubmitDate': '2024-04-22', 'studyFirstSubmitQcDate': '2024-05-07', 'lastUpdatePostDateStruct': {'date': '2025-01-10', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2024-05-13', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-09-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Semispinalis capitis state of tension', 'timeFrame': 'Baseline', 'description': 'To assess the tension of the semispinalis capitis (SC), participants will lie in a supine position on the treatment table. The physiotherapist will identify the measurement point using a pencil. This point will be located approximately two finger widths lateral to the spinous process of the C7 vertebra and slightly inferior to the occiput (base of the skull). The device will be held vertically and a consistent downward pressure of 18 Newtons (N) will be applied to the muscle belly. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Semispinalis capitis biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of the semispinalis capitis (SC), participants will lie in a supine position on the treatment table. The physiotherapist will identify the measurement point using a pencil. This point will be located approximately two finger widths lateral to the spinous process of the C7 vertebra and slightly inferior to the occiput (base of the skull). The device will be held vertically and a consistent downward pressure of 18 Newtons (N) will be applied to the muscle belly. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Semispinalis capitis viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess the viscoelastic properties of the semispinalis capitis (SC), participants will lie in a supine position on the treatment table. The physiotherapist will identify the measurement point using a pencil. This point will be located approximately two finger widths lateral to the spinous process of the C7 vertebra and slightly inferior to the occiput (base of the skull). The device will be held vertically and a consistent downward pressure of 18 Newtons (N) will be applied to the muscle belly. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Sternocleidomastoideus (SCM) state of tension', 'timeFrame': 'Baseline', 'description': 'To assess the tension of the sternocleidomastoideus (SCM), participants will lie supine on the treatment table. The evaluator will locate the midpoint on a line between the mastoid process (behind the ear) and the clavicle (collarbone), marking this point with a pencil. The device will be held vertically and a consistent downward pressure of 18 Newtons (N) will be applied to the muscle belly. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Sternocleidomastoideus (SCM) biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of the sternocleidomastoideus (SCM), participants will lie supine on the treatment table. The evaluator will locate the midpoint on a line between the mastoid process (behind the ear) and the clavicle (collarbone), marking this point with a pencil. The device will be held vertically and a consistent downward pressure of 18 Newtons (N) will be applied to the muscle belly. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Sternocleidomastoideus (SCM) viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess the viscoelastic properties of the sternocleidomastoideus (SCM), participants will lie supine on the treatment table. The evaluator will locate the midpoint on a line between the mastoid process (behind the ear) and the clavicle (collarbone), marking this point with a pencil. The device will be held vertically and a consistent downward pressure of 18 Newtons (N) will be applied to the muscle belly. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Trapezius state of tension', 'timeFrame': 'Baseline', 'description': 'To assess the tension of the trapezius, participants will sit upright in a chair with good back support. Their hips should touch the back of the chair, feet flat on the floor, and hands resting comfortably in their lap. Shoulders will be relaxed, and knees and hips bent at a 90-degree angle. The upper trapezius measurement point is midway between the C7 vertebra (prominent at the base of the neck) and the acromion (the bony tip of the shoulder). The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Trapezius biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of the trapezius, participants will sit upright in a chair with good back support. Their hips should touch the back of the chair, feet flat on the floor, and hands resting comfortably in their lap. Shoulders will be relaxed, and knees and hips bent at a 90-degree angle. The upper trapezius measurement point is midway between the C7 vertebra (prominent at the base of the neck) and the acromion (the bony tip of the shoulder). The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Trapezius viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess the viscoelastic properties of the trapezius, participants will sit upright in a chair with good back support. Their hips should touch the back of the chair, feet flat on the floor, and hands resting comfortably in their lap. Shoulders will be relaxed, and knees and hips bent at a 90-degree angle. The upper trapezius measurement point is midway between the C7 vertebra (prominent at the base of the neck) and the acromion (the bony tip of the shoulder). The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Deltoid state of tension', 'timeFrame': 'Baseline', 'description': 'To assess deltoid tension, participants will lie in the supine position. The physiotherapist will locate the measurement point using a pencil. This point will be roughly halfway down the muscle, centered between the lateral aspect of the acromion process (bony point of the shoulder) and the insertion point on the deltoid tuberosity (bumpy area near the midpoint of the upper arm bone). The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Deltoid biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of the deltoid muscle, participants will lie in the supine position. The physiotherapist will locate the measurement point using a pencil. This point will be roughly halfway down the muscle, centered between the lateral aspect of the acromion process (bony point of the shoulder) and the insertion point on the deltoid tuberosity (bumpy area near the midpoint of the upper arm bone). The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Deltoid viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess deltoid viscoelastic properties, participants will lie in the supine position. The physiotherapist will locate the measurement point using a pencil. This point will be roughly halfway down the muscle, centered between the lateral aspect of the acromion process (bony point of the shoulder) and the insertion point on the deltoid tuberosity (bumpy area near the midpoint of the upper arm bone). The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Biceps brahii state of tension', 'timeFrame': 'Baseline', 'description': 'To assess biceps brachii tension, participants will lie supine on the treatment table with their arms at their sides and palms facing upwards. The physiotherapist will locate the measurement point on the front of the upper arm, approximately midway between the shoulder and elbow crease. Using a pencil, they will mark this point. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Biceps brahii biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of biceps brachii, participants will lie supine on the treatment table with their arms at their sides and palms facing upwards. The physiotherapist will locate the measurement point on the front of the upper arm, approximately midway between the shoulder and elbow crease. Using a pencil, they will mark this point. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Biceps brahii viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess the biceps brachii viscoelastic properties, participants will lie supine on the treatment table with their arms at their sides and palms facing upwards. The physiotherapist will locate the measurement point on the front of the upper arm, approximately midway between the shoulder and elbow crease. Using a pencil, they will mark this point. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Brachioradialis state of tension', 'timeFrame': 'Baseline', 'description': 'To assess brachioradialis tension, participants will lie supine on the treatment table with their arms at their sides and palms facing upwards. The physiotherapist will locate the measurement point on the front of the upper arm, approximately midway between the shoulder and elbow crease. Using a pencil, they will mark this point. The device will be held vertically and a steady downward pressure of 18 Newtons (N) will be applied directly over the marked point. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Brachioradialis biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of brachioradialis, participants will lie supine on the treatment table with their arms at their sides and palms facing upwards. The physiotherapist will locate the measurement point on the front of the upper arm, approximately midway between the shoulder and elbow crease. Using a pencil, they will mark this point. The device will be held vertically and a steady downward pressure of 18 Newtons (N) will be applied directly over the marked point. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Brachioradialis viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess brachioradialis viscoelastic properties, participants will lie supine on the treatment table with their arms at their sides and palms facing upwards. The physiotherapist will locate the measurement point on the front of the upper arm, approximately midway between the shoulder and elbow crease. Using a pencil, they will mark this point. The device will be held vertically and a steady downward pressure of 18 Newtons (N) will be applied directly over the marked point. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Rectus femoris state of tension', 'timeFrame': 'Baseline', 'description': 'To assess rectus femoris tension, participants will lie supine on a treatment table. The physiotherapist will locate the measurement point along the front of the thigh, approximately halfway between the anterior superior iliac spine (hip bone) and the top of the patella (kneecap). A pencil will be used to mark this point. The device will be held vertically, and a steady downward pressure of 18 Newtons (N) will be applied directly over the marked point. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Rectus femoris biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess the biomechanical properties of the rectus femoris, participants will lie supine on a treatment table. The physiotherapist will locate the measurement point along the front of the thigh, approximately halfway between the anterior superior iliac spine (hip bone) and the top of the patella (kneecap). A pencil will be used to mark this point. The device will be held vertically, and a steady downward pressure of 18 Newtons (N) will be applied directly over the marked point. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Rectus femoris viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess rectus femoris viscoelastic properties, participants will lie supine on a treatment table. The physiotherapist will locate the measurement point along the front of the thigh, approximately halfway between the anterior superior iliac spine (hip bone) and the top of the patella (kneecap). A pencil will be used to mark this point. The device will be held vertically, and a steady downward pressure of 18 Newtons (N) will be applied directly over the marked point. Once the indicator light on the probe transitions from red to green, pressure will be maintained while the MyotonPRO delivers five stimulation pulses. The following will be assessed:\n\nTViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Vastus medialis state of tension', 'timeFrame': 'Baseline', 'description': 'To assess vastus medialis tension, participants will lie in a supine position on the treatment table with their legs extended. The physiotherapist will locate the measurement point on the inner thigh, approximately one hand-width above the superior-medial border of the patella (kneecap). This point should align with the visible bulge of the vastus medialis muscle. A pencil will be used to mark this point. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Vastus medialis biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess vastus medialis biomechanical properties, participants will lie in a supine position on the treatment table with their legs extended. The physiotherapist will locate the measurement point on the inner thigh, approximately one hand-width above the superior-medial border of the patella (kneecap). This point should align with the visible bulge of the vastus medialis muscle.A pencil will be used to mark this point. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Vastus medialis viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess vastus medialis viscoelastic properties, participants will lie in a supine position on the treatment table with their legs extended. The physiotherapist will locate the measurement point on the inner thigh, approximately one hand-width above the superior-medial border of the patella (kneecap). This point should align with the visible bulge of the vastus medialis muscle.A pencil will be used to mark this point. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Vastus lateralis state of tension', 'timeFrame': 'Baseline', 'description': 'To assess vastus lateralis tension, participants will lie in a supine position on the treatment table with their leg extended. The physiotherapist will locate the measurement point on the outer thigh, approximately one hand-width above the superior-lateral border of the patella (kneecap). This point should align with the pronounced bulge of the vastus lateralis muscle. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Vastus lateralis biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess vastus lateralis biomechanical properties, participants will lie in a supine position on the treatment table with their leg extended. The physiotherapist will locate the measurement point on the outer thigh, approximately one hand-width above the superior-lateral border of the patella (kneecap). This point should align with the pronounced bulge of the vastus lateralis muscle. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Vastus lateralis viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess vastus lateralis viscoelastic properties, participants will lie in a supine position on the treatment table with their leg extended. The physiotherapist will locate the measurement point on the outer thigh, approximately one hand-width above the superior-lateral border of the patella (kneecap). This point should align with the pronounced bulge of the vastus lateralis muscle. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}, {'measure': 'Tibialis anterior state of tension', 'timeFrame': 'Baseline', 'description': 'To assess tibialis anterior tension, participants will sit comfortably in a chair with their feet flat on the floor. The physiotherapist will locate the measurement point on the front of the lower leg, approximately one-third of the distance between the knee and the ankle. This point typically aligns with the most prominent bulge of the tibialis anterior muscle. The following will be assessed:\n\nTone or state of tension: F - Natural Oscillation Frequency \\[Hz\\].'}, {'measure': 'Tibialis anterior biomechanical properties', 'timeFrame': 'Baseline', 'description': 'To assess tibialis anterior biomechanical properties, participants will sit comfortably in a chair with their feet flat on the floor. The physiotherapist will locate the measurement point on the front of the lower leg, approximately one-third of the distance between the knee and the ankle. This point typically aligns with the most prominent bulge of the tibialis anterior muscle. The following will be assessed:\n\nBiomechanical properties: S-Dynamic Stiffness \\[N/m\\].'}, {'measure': 'Tibialis anterior viscoelastic properties', 'timeFrame': 'Baseline', 'description': 'To assess tibialis anterior viscoelastic properties, participants will sit comfortably in a chair with their feet flat on the floor. The physiotherapist will locate the measurement point on the front of the lower leg, approximately one-third of the distance between the knee and the ankle. This point typically aligns with the most prominent bulge of the tibialis anterior muscle. The following will be assessed:\n\nViscoelastic properties: R-Mechanical Stress Relaxation Time \\[ms\\].'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['COPD', 'Muscle tone', 'Muscle stiffness', 'Muscle mechanical proprieties'], 'conditions': ['Copd', 'Muscle Weakness', 'Muscle Weakness Condition']}, 'descriptionModule': {'briefSummary': 'This study aims to determine if patients with Chronic Obstructive Pulmonary Disease (COPD) exhibit altered muscle properties (specifically changes in tone and stiffness) in both their respiratory muscles and skeletal muscles when compared to healthy individuals. The study will utilize the Myotonometer, a non-invasive device, to assess these properties.', 'detailedDescription': 'Chronic Obstructive Pulmonary Disease (COPD) leads to progressive airflow limitation and respiratory muscle dysfunction, contributing to exercise intolerance and reduced quality of life. While existing methods evaluate overall lung function, the assessment of specific respiratory muscle properties remains challenging. Myotonometry offers a non-invasive technique to quantify muscle tone and stiffness, potentially providing insights into respiratory and skeletal muscle mechanics in COPD. This study aims to explore differences in the mechanical properties of both superficial respiratory and skeletal muscles in patients with COPD compared to healthy controls using myotonometry. Investigators hypothesize that COPD patients will exhibit altered mechanical properties (e.g., increased stiffness and tone) in both superficial respiratory and skeletal muscles compared to healthy controls.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '75 Years', 'minimumAge': '45 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Individuals with COPD and healthy subjects', 'healthyVolunteers': True, 'eligibilityCriteria': "Inclusion criteria for the COPD group:\n\nDiagnosis of COPD: Confirmed diagnosis of COPD based on GOLD spirometry criteria:\n\nPost-bronchodilator FEV1/FVC ratio \\< 0.70 Documented history of respiratory symptoms (e.g., dyspnea, cough, sputum production) Stable COPD: No COPD exacerbations requiring hospitalization in the past 6 months.\n\nSmoking History: Current or former smoker with a documented smoking history of at least 10 pack-years (cumulative cigarette consumption).\n\nAge: 45-75 years old. Ability to Understand and Follow Instructions: Mentally competent and able to understand the study procedures, risks, and benefits, providing written informed consent.\n\nExclusion criteria for the COPD group:\n\nOther respiratory disease than COPD. Severe COPD exacerbation: anyone with a COPD exacerbation requiring hospitalization within the last six months.\n\nConditions limiting chest wall movement: severe kyphosis, ankylosing spondylitis, or similar conditions that significantly impact the ability to expand the chest wall and perform respiratory muscle assessments.\n\nMuscular or neuromuscular disorders: primary muscular diseases (e.g., muscular dystrophy) or neuromuscular disorders affecting muscle function (e.g., Parkinson's, multiple sclerosis).\n\nRecent Surgery or Trauma: Significant surgery or trauma within the past three months that might affect muscle function or the ability to perform assessments.\n\nUncontrolled comorbidities: severe, uncontrolled medical conditions that could significantly impact muscle function or confound the study results (e.g., uncontrolled heart failure, advanced renal disease).\n\nInclusion criteria for the healthy control group:\n\nNo History of Respiratory Disease: free from any current or past respiratory diagnoses, including asthma, chronic bronchitis, or recurrent respiratory infections.\n\nNormal lung function: spirometry testing will confirm normal lung function with a post-bronchodilator FEV1/FVC ratio \\> 0.70 and no evidence of airflow obstruction.\n\nNo significant chronic conditions: free from any major chronic medical conditions that could impact muscle function or confound the results (e.g., uncontrolled diabetes, heart failure, advanced liver disease).\n\nAge: 45-75 years old Ability to understand and follow instructions: mentally competent and able to understand the study procedures, risks, and benefits, providing written informed consent.\n\nNo recent infections: free from any recent respiratory or other infections within the past 4 weeks.\n\nNon-smoker or minimal smoking history: non-smokers or have a very minimal smoking history (less than 10 pack-years)\n\nExclusion criteria for the healthy control group:\n\nRecent respiratory infection: anyone with a current respiratory tract infection (viral or bacterial) within the past four weeks.\n\nMild respiratory symptoms: Even mild, persistent respiratory symptoms (chronic cough, sputum production) within the past 4 weeks.\n\nConditions limiting chest wall movement: severe kyphosis, ankylosing spondylitis, or similar conditions that significantly impact the ability to expand the chest wall and perform respiratory muscle assessments.\n\nMuscular or neuromuscular disorders: primary muscular diseases (e.g., muscular dystrophy) or neuromuscular disorders affecting muscle function (e.g., Parkinson's, multiple sclerosis).\n\nRecent Surgery or Trauma: Significant surgery or trauma within the past three months that might affect muscle function or the ability to perform assessments.\n\nUncontrolled comorbidities: severe, uncontrolled medical conditions that could significantly impact muscle function or confound the study results (e.g., uncontrolled heart failure, advanced renal disease)."}, 'identificationModule': {'nctId': 'NCT06410950', 'briefTitle': 'Mechanical Muscle Proprieties in Patient with COPD', 'organization': {'class': 'OTHER_GOV', 'fullName': 'Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara'}, 'officialTitle': 'Exploring Muscle Proprieties in COPD: a Non-invasive Evaluation of Respiratory and Limb Muscle Mechanics Using Myotonometry.', 'orgStudyIdInfo': {'id': '3654/04'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'COPD subjects', 'description': 'Individuals diagnosed with COPD based on GOLD spirometry criteria (post-bronchodilator FEV1/FVC ratio \\< 0.70).\n\nStable COPD with no exacerbations requiring hospitalization in the past six months.\n\nAge range: 45-75 years old.', 'interventionNames': ['Diagnostic Test: MyotonPRO Assessment of Muscle Biomechanical Properties']}, {'label': 'Healthy subjects', 'description': 'Individuals with no history of chronic respiratory disease or recent infections.\n\nNormal lung function on spirometry (post-bronchodilator FEV1/FVC ratio \\> 0.70). Age range: 40-75 years old.', 'interventionNames': ['Diagnostic Test: MyotonPRO Assessment of Muscle Biomechanical Properties']}], 'interventions': [{'name': 'MyotonPRO Assessment of Muscle Biomechanical Properties', 'type': 'DIAGNOSTIC_TEST', 'description': "Muscle assessments will be conducted using the MyotonPRO (Myoton AS., Tallinn, Estonia) digital palpation device. Measurement patterns and subject data will be uploaded to the device via computer. Each evaluation will be performed bilaterally.\n\nSubjects' muscle measurement points will be marked prior to assessment. The physiotherapist will position the device perpendicular to the muscle body and apply downward pressure (18N). Pressure should be maintained until the device's probe light changes from red to green. Five measurement pulses will then be applied. Each pulse lasts 15 ms with an 8 ms interval between pulses.\n\nThe SENIAM sensor location guide will be used to determine the approximate motor point for MyotonPRO measurements.", 'armGroupLabels': ['COPD subjects', 'Healthy subjects']}]}, 'contactsLocationsModule': {'locations': [{'zip': '300301', 'city': 'Timișoara', 'state': 'Timiș County', 'country': 'Romania', 'facility': 'Spitalul de Boli Infectioase si Pneumoftiziologie Victor Babes', 'geoPoint': {'lat': 45.75372, 'lon': 21.22571}}], 'overallOfficials': [{'name': 'Alexandru Crișan, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara', 'class': 'OTHER_GOV'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Crisan Alexandru Florian', 'investigatorAffiliation': 'Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara'}}}}